Literature DB >> 25809924

Hypothesis testing for two-stage designs with over or under enrollment.

Donglin Zeng1, Fei Gao1, Kuolung Hu2, Catherine Jia2, Joseph G Ibrahim1.   

Abstract

Simon's two-stage designs are widely used in cancer phase II clinical trials for assessing the efficacy of a new treatment. However in practice, the actual sample size for the second stage is often different from the planned sample size, and the original inference procedure is no longer valid. Previous work on this problem has certain limitations in computation. In this paper, we attempt to maximize the unconditional power while controlling for the type I error for the modified second stage sample size. A normal approximation is used for computing the power, and the numerical results show that the approximation is accurate even under small sample sizes. The corresponding confidence intervals for the response rate are constructed by inverting the hypothesis test, and they have reasonable coverage while preserving the type I error.
Copyright © 2015 John Wiley & Sons, Ltd.

Entities:  

Keywords:  adaptive design; clinical trials; sample size modification

Mesh:

Year:  2015        PMID: 25809924      PMCID: PMC4636905          DOI: 10.1002/sim.6490

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  7 in total

1.  Planned versus attained design in phase II clinical trials.

Authors:  S J Green; S Dahlberg
Journal:  Stat Med       Date:  1992-05       Impact factor: 2.373

2.  Optimal flexible designs in phase II clinical trials.

Authors:  T T Chen; T H Ng
Journal:  Stat Med       Date:  1998-10-30       Impact factor: 2.373

3.  Optimal two-stage designs allowing flexibility in number of subjects for phase II clinical trials.

Authors:  Nobuyuki Masaki; Tatsuki Koyama; Isao Yoshimura; Chikuma Hamada
Journal:  J Biopharm Stat       Date:  2009-07       Impact factor: 1.051

4.  Optimal two-stage designs for phase II clinical trials.

Authors:  R Simon
Journal:  Control Clin Trials       Date:  1989-03

5.  A Bayesian approach for unplanned sample sizes in phase II cancer clinical trials.

Authors:  Yimei Li; Rosemarie Mick; Daniel F Heitjan
Journal:  Clin Trials       Date:  2012-04-20       Impact factor: 2.486

6.  Proper inference from Simon's two-stage designs.

Authors:  Tatsuki Koyama; Heidi Chen
Journal:  Stat Med       Date:  2008-07-20       Impact factor: 2.373

7.  What inference for two-stage phase II trials?

Authors:  Raphaël Porcher; Kristell Desseaux
Journal:  BMC Med Res Methodol       Date:  2012-08-06       Impact factor: 4.615

  7 in total
  3 in total

1.  Optimal inference for Simon's two-stage design with over or under enrollment at the second stage.

Authors:  Guogen Shan; John J Chen
Journal:  Commun Stat Simul Comput       Date:  2017-06-20       Impact factor: 1.118

2.  Exact confidence limits for the response rate in two-stage designs with over- or under-enrollment in the second stage.

Authors:  Guogen Shan
Journal:  Stat Methods Med Res       Date:  2016-07-07       Impact factor: 3.021

3.  Statistical inference for extended or shortened phase II studies based on Simon's two-stage designs.

Authors:  Junjun Zhao; Menggang Yu; Xi-Ping Feng
Journal:  BMC Med Res Methodol       Date:  2015-06-07       Impact factor: 4.615

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.